Save time and get answers to complex questions with AI chat
Is guselkumab off patent in u s?Zemdri nce gain exclusivity 2028 patent 2031?Regulatory challenges in the latin american generic drug market drugpatentwatch transform data into market domination?How to apply for vascepa's patient assistance?When is xarelto's patent set to expire roughly?
See the DrugPatentWatch profile for prolia
Prolia (denosumab) came on the market in 2010 after the drug received regulatory approval that year for treatment and prevention of osteoporosis in appropriate patient groups.
Prolia’s first widespread availability is commonly tied to its 2010 approval and subsequent rollout by the manufacturer in major markets, which is why many references list 2010 as its “came to market” year.
“On the market” can vary by country (US vs. EU vs. others) because approvals and commercial launches don’t always happen on the same day. If you tell me which country (for example, United States or European Union), I can narrow it to the most likely approval/launch timing for that specific market.
Other Questions About Prolia :